Searched for
FRESENIUS KABI
Complaint filed against Natco Pharma in US by Fresenius KabiNatco Pharma faces a legal complaint from Fresenius Kabi in the US District Court regarding the marketing of Diazepam injection prefilled s...- Fresenius Kabi gets 2 months extension for delisting offerFresenius Kabi Oncology today said Securities Appellate Tribunal (SAT) has granted it an extension of two months to complete its delisting ...
- USFDA issues warning letter to Fresenius Kabi OncologyUS health regulator has issued a warning letter to Fresenius Kabi Oncology for violation of manufacturing norms at its Kalyani facility in ...
- USFDA issues warning letter to Fresenius Kabi OncologyFresenius Kabi Oncology today said it has received a warning letter from the US health regulator asking for more information and implementa...
- Promoters want to delist Fresenius Kabi Oncology from boursesFresenius Kabi (Singapore) Pte Ltd is planning to delist its Indian arm Fresenius Kabi Oncology by buying out 19 % stake held by the public.
- Parenteral Drugs to sell unit to Fresenius Kabi for Rs 200 crParenteral Drugs today said its subsidiary, Goa Formulations has entered into an agreement with Fresenius Kabi India to sell its manufactur...
- Buy Fresenius Kabi Oncology with a target of 108: Sandeep WagleFresenius Kabi Oncology Ltd is a ‘BUY’ call with a target of Rs 108 and a stop loss of Rs 92.50.
- Fresenius Kabi to pay higher compensation to clinical trial victimsFresenius Kabi Oncology, the Indian arm of Germany's Fresenius Kabi will increase the compensation it paid to families of two volunteers wh...
- Heard on the Street: Kabi Oncology soars on delisting talkShares of Fresenius Kabi Oncology were among the top gainers in an otherwise weak market as the market speculated the possibility of a deli...
- Fresenius Kabi's India unit now global R&D hubFresenius Kabi Oncology has restructured its business, making it one of the global R&D and manufacturing hubs for the German promoter.
- Germany's Fresenius recalls India-made drugs shipped to USGerman drug co recalled two batches of cancer drug made by its Indian arm on cross-contamination.
- Fresenius Kabi allots 0.99% stake to Atlas VermoegansverwaltunghFresenius Kabi Oncology (formerly Dabur Pharma) is making a preferential allotment of 15.5 lakh shares amounting to 0.99% stake to Frankfur...
- Dabur Pharma gets Government nod for name changeDabur Pharma on Tuesday said it has received the government's approval for changing its name to Fresenius Kabi Oncology.
- Fresenius Kabi to invest 30 mn euros in Dabur’s API plantFresenius Kabi, which acquired the Burmans’ pharma business early this year, will invest around 30 euros million in the active pharmaceutic...
- Open offer to Dabur Pharma shareholders rescheduledDabur Pharma on Tuesday said the open offer to its shareholders by German firm Fresenius Kabi has been rescheduled and will now begin on Ju...
- Fresenius Kabi makes open offer to buy 20% of Dabur PharmaFresenius Kabi, an arm of German healthcare group Fresenius SE, on Wednesday made an open offer to buy an additional 20 per cent in Burman ...
- Fresenius Kabi to invest $70 mn, announces open offerDays after acquiring 73.3 per cent control of Dabur Pharma, European health care firm Fresenius Kabi on Monday said it would launch a publi...
- German co Fresenius Kabi picks up 73% in Dabur PharmaGerman co Fresenius Kabi acquired the stake in Dabur Pharma for around Rs 872 cr. With this, the Burman family exits pharmaceutical biz. Go...
- Singapore firm to acquire 73.27% stake in Dabur PharmaHome grown drug maker Dabur Pharma on Saturday said it will sell 73.27 per cent stake to Fresenius Kabi (Singapore) Pte Ltd for an undisclo...
- Fresenius Kabi to expand product portfolio in IndiaFresenius Kabi plans to expand its product portfolio in India in next one year and is awaiting approval for the same from the regulators.
Load More- USFDA issues warning letter to Fresenius Kabi Oncology
